Early biomarker diagnostics at the bedside.


EarlyBio's proprietary eCyto-technology will standardize the detection of early but unstable cell biomarkers in whole blood at the bedside. These biomarkers are predictive but not used in diagnostics due to the lack of standardization. The test will deliver results in 10-15 minutes and is simple as blood drawing.

The results will support surgeons and anesthesists in making objective emergency decisions
in order to prevent expensive post-surgical complications and to reduce mortality.

The EarlyBio website is under construction.